NanoMosaic

NanoMosaic, Inc., a pioneer and leader in nanoneedle-based detection for proteomics and multi-omics applications based in Massachusetts, utilizes MosaicNeedles™ nanoneedles for protein detection and quantification to develop assays for biomarker discovery and validation. The NanoMosaic platform, Tessie™, provides an end-to-end solution for performing homologous protein queries and multi-omics analyses in a single chip all at once. This technology enables end users to rapidly customize assay development for proteomics and nucleic acid content.